Astellas: EC approves PADCEV combination for first-line treatment of advanced urothelial cancer

Posted on August 28, 2024 by Vaseline

KENILWORTH (NJ) (dpa-AFX) – Astellas Pharma Inc. (ALPMY, ALPMY) announced that the European Commission has granted a marketing authorization for Astellas Pharma Inc. (ALPMY, ALPMY) …

Posted in bookmarks

Previous: EC approves PADCEV combination for first-line treatment of advanced urothelial cancer

Next: Huawei Factory AI Chip Launch: Will NVIDIA Become the New Competition? | 28.08.24

bookmarks

In Kassel da gibt’s ein Café Jihad – Antisemitismus als Beigabe zur Museumsnacht

Vaseline
August 21, 2024
0

Kasseler Museum Photo: Jonas Dörge In Kassel, in the Germaniastraße, it is a café, which is of course not Café Wotan and not Café Jihad, […]

bookmarks

Reolink: New, smart Türklingel starts with higher Auflösung and Zwei-Wege-Communikation – and Akku

Vaseline
September 18, 2024
0

In summary: Reolink Battery Doorbell (Image: Reolink) Reolink is a new and useful Türklingel function. These are a strong Enlightenment Mitbringen and Unterstützt a wide […]

bookmarks

Bohnen einkochen: So that’s the end barmachen

Vaseline
August 17, 2024
0

It is possible that Trockenbohnen (ein)zukochen. If you want to know more, no matter how wise you are – if you spend the night – […]

Related Posts

In Kassel da gibt’s ein Café Jihad – Antisemitismus als Beigabe zur Museumsnacht

Reolink: New, smart Türklingel starts with higher Auflösung and Zwei-Wege-Communikation – and Akku

Bohnen einkochen: So that’s the end barmachen